BackBiofrontera Overview

Biofrontera Profit Margin

Latest profit margin for Biofrontera: -12.72% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-70.82%
↑ 25.57% YoY

As of Sep 2026

Annual Profit Margin (TTM)

-12.72%
↑ 73.10% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Biofrontera (BFRI) FAQ

Biofrontera (BFRI) currently reports a profit margin of -12.72% as of September 2026. That compares with -47.29% in the prior-year period — up 73.1% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore Biofrontera's profit margin history and peer comparisons.

Biofrontera's profit margin increased from -47.29% to -12.72% — a 73.1% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biofrontera's profit margin of -12.72% is lower than the Healthcare sector average of 17.63%. That is roughly 172.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Biofrontera's current -12.72% should be judged against Healthcare norms (sector average: 17.63%) and against BFRI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -12.72%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Biofrontera, and consider following BFRI for alerts when major investors trade the stock.